The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 435K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vercammen, D.
Right arrow Articles by Vandenabeele, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vercammen, D.
Right arrow Articles by Vandenabeele, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/9/919/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 5, September 7, 1998 919-930


Articles

Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

Dominique Vercammen, Greet Brouckaert, Geertrui Denecker, Marc Van de Craen, Wim Declercq, Walter Fiers, and Peter Vandenabeele

From the Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium

Murine L929 fibrosarcoma cells were transfected with the human Fas (APO-1/CD95) receptor, and the role of various caspases in Fas-mediated cell death was assessed. Proteolytic activation of procaspase-3 and -7 was shown by Western analysis. Acetyl-Tyr-Val-Ala-Asp-chloromethylketone and benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone, tetrapeptide inhibitors of caspase-1– and caspase-3–like proteases, respectively, failed to block Fas-induced apoptosis. Unexpectedly, the broad-spectrum caspase inhibitors benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone and benzyloxycarbonyl-Asp(OMe)-fluoromethylketone rendered the cells even more sensitive to Fas-mediated cell death, as measured after 18 h incubation. However, when the process was followed microscopically, it became clear that anti-Fas–induced apoptosis of Fas-transfected L929 cells was blocked during the first 3 h, and subsequently the cells died by necrosis. As in tumor necrosis factor (TNF)-induced necrosis, Fas treatment led to accumulation of reactive oxygen radicals, and Fas-mediated necrosis was inhibited by the oxygen radical scavenger butylated hydroxyanisole. However, in contrast to TNF, anti-Fas did not activate the nuclear factor {kappa}B under these necrotic conditions. These results demonstrate the existence of two different pathways originating from the Fas receptor, one rapidly leading to apoptosis, and, if this apoptotic pathway is blocked by caspase inhibitors, a second directing the cells to necrosis and involving oxygen radical production.

Key Words: Fas antigen • apoptosis • necrosis • caspases • oxygen radicals


Address correspondence to P. Vandenabeele, Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, K.L. Ledeganckstraat 35, B-9000 Ghent, Belgium. Phone: 32-9-264-51-31; Fax: 32-9-264-53-48; E-mail: petervda{at}lmb.rug.ac.be

Research was supported by the Interuniversitaire Attractiepolen, grant 9005097N of the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen, and European Community Biomed Program grant BMH4-CT96-0300. G. Denecker is a research assistant, and P. Vandenabeele a postdoctoral researcher with the Fonds voor Wetenschappelijk Onderzoek–Vlaanderen.

Abbreviations used: Ac-DEVD-amc, acetyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-aminomethylcoumarin; Ac-YVAD-amc, acetyl-Tyr-Val-Ala-Asp-aminomethylcoumarin; Ac-YVAD-cmk, acetyl-Tyr-Val-Ala-Asp-chloromethylketone; BHA, butylated hydroxyanisole; DD, death domain; DR, death receptor; DHR123, dihydrorhodamine, 123; FADD, Fas-associated DD protein; L929hFas, Fas-transfected L929 (cells); MORT, mediator of receptor-induced toxicity; NF-{kappa}B, nuclear factor {kappa}B; PI, propidium iodide; TRADD, TNFR-associated DD protein; TRAIL, TNF- related apoptosis–inducing ligand; zAAD-cmk, benzyloxycarbonyl-Ala-Ala-Asp-chloromethylketone; zDEVD-fmk, benzyloxycarbonyl-Asp(OMe)- Glu(OMe)-Val-Asp(OMe)-fluoromethylketone; zD-fmk, benzyloxycarbonyl-Asp(OMe)-fluoromethylketone; zVAD-afc, benzyloxycarbonyl-Val-Ala-Asp(OMe)-aminotrifluoromethylcoumarin; zVAD-fmk, benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS